Skip to content

What Peptides Does Joe Rogan Take? What He Has Said on Record

Joe Rogan has said BPC-157 cleared his elbow tendonitis and that he had an NAD drip for COVID-19. The dates, the sources and what the research shows.

Sebastian Hunter, Founder and EditorWritten bySebastian Hunter, Founder and EditorI'm a 42-year-old senior advisor and distance runner who came to peptides as a sceptic. I'm not a doctor: I read the research, run my own experiment and keep honest notes. Read full bio

The short version

Two things Joe Rogan has said are confirmed by a dated source and a second report. In July 2021 he said on his podcast that BPC-157 cleared elbow tendonitis within two weeks. In September 2021 he said he had an NAD drip, among several treatments, while ill with COVID-19. NAD is a coenzyme, not a peptide. Neither statement shows what the compound does, and neither says what he takes now.

  • BPC-157: on episode #1683 (July 2021) Rogan said his elbow tendonitis was gone within two weeks.
  • NAD: in a September 2021 Instagram video he said he had an NAD drip, alongside several COVID-19 treatments.
  • Neither statement says what he takes now, and neither names a supplier.
  • BPC-157 is sold as a research chemical; the one trial testing whether it works against a placebo found no significant benefit.
  • Andrew Huberman has said on his own podcast that he tried BPC-157, sermorelin, pinealon and an NAD infusion.

BPC-157 is the one peptide Joe Rogan has named in a statement I could confirm: in July 2021 he said it cleared his elbow tendonitis within two weeks. He has also said he had an NAD drip while ill with COVID-19 that year. NAD is a coenzyme, not a peptide.

CompoundWhat he saidWhenWhereEvidence ratingUS legal status
BPC-157Elbow tendonitis he “could not fix” was gone within two weeks14 July 2021The Joe Rogan Experience #1683LimitedResearch chemical, not FDA-approved
NAD+ (not a peptide)Had an NAD drip and a vitamin drip, three days in a row, while ill with COVID-191 September 2021Instagram videoLimitedNo FDA-approved product found

Joe Rogan and BPC-157: the elbow tendonitis story

What he said. On The Joe Rogan Experience #1683, released 14 July 2021 with guest Andrew Huberman, Rogan said a doctor had told him BPC-157 didn’t work. He answered that he had used it himself and said: “I had a tendonitis in my elbow that I just could not fix”. It was gone, he said, within two weeks of starting BPC-157 (episode transcript).

The source. The transcript is automatic and doesn’t label speakers. The Associated Press quoted the same account in November 2025, attributed it to Rogan, and said he has “repeatedly praised” BPC-157 (AP, via ABC11). The AP dated the remark it quoted to 2024 (“last year”); the 2021 episode is the earliest version I found.

What it shows. One person’s account of one injury. It can’t separate the peptide from natural healing, rest or anything else he did at the time.

What the research shows. BPC-157 rates “limited” on this site’s evidence scale. Rat studies of tendon, ligament and muscle healing are consistently positive, but benefit in humans has not been confirmed (Gwyer 2019 - Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159., in the references below).

FDA’s July 2026 briefing lists five small human studies, in which about 80 people received BPC-157 (FDA briefing). Only one tested whether it works against a placebo: a trial in 53 people with ulcerative colitis, which found no significant difference. The closest study to Rogan’s use looked back at 17 knee-pain patients, followed up by phone, with no comparison group (Lee 2021 - Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med. 2021;27(4):8-13., in the references below). The full picture is on the BPC-157 page.

Legal status. BPC-157 is not FDA-approved for anything. It is sold as a research chemical labelled not for human use, and pharmacies can’t currently compound it. In July 2026 FDA’s compounding advisory committee voted 8-6 to recommend letting them. The vote is non-binding (ABC News). As of 3 October 2026 the Federal Register holds no rule adding it to the list pharmacies may compound from (Federal Register search). It is also banned in sport (AP).

Joe Rogan and NAD: the drip during COVID-19

What he said. Rogan announced in an Instagram video on 1 September 2021 that he had COVID-19. He listed monoclonal antibodies, ivermectin, a Z-Pak and prednisone, and said he also had “an NAD drip and a vitamin drip”, three days in a row. By the Wednesday, he said, he felt great.

The source. Two news reports quote the video: CBS News on 1 September 2021 and Variety on 8 September 2021. Neither gives a dose or a brand.

What it shows. He took several treatments at once, so his recovery can’t be credited to any one of them.

What the research shows. NAD+ is a coenzyme the body uses in cell metabolism and DNA repair (Reyna 2026 - Reyna K, Heinzen G, Patel N et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD(+)) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026;7:1652582., in the references below). NAD+ injection rates “limited” on this site’s evidence scale. The two published human studies of IV NAD+ I have verified measured blood levels during a 6-hour infusion (Grant 2019 - Grant R, Berg J, Mestayer R et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. Front Aging Neurosci. 2019;11:257., in the references below) and tolerability in clinic records (Reyna 2026 - Reyna K, Heinzen G, Patel N et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD(+)) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026;7:1652582., in the references below). Neither measured recovery from an infection.

In the clinic study, people given NAD+ reported moderate to severe gut symptoms, a faster heart rate and chest pressure during infusions. The full picture is on the NAD+ injection page.

Legal status. I found no FDA-approved NAD+ product in FDA’s Drugs@FDA database on 3 October 2026. NAD+ injections are made by compounding pharmacies.

In a January 2026 warning letter, FDA told one compounder that NAD+ is not eligible for its type of compounding. The letter also describes three patients sent to the emergency room after NAD+ from a single lot. An unopened vial from that lot held excessive bacterial endotoxins (FDA warning letter).

What Rogan hasn’t said on record

  • What he takes now. Neither statement describes current use.
  • A supplier. Neither statement names a company. To check any seller yourself, see the vendor checklist and how to read a peptide COA.
  • Other peptides. I found no Rogan statement naming another peptide, such as TB-500 or ipamorelin, that I could confirm against a dated source and a second report.

What Andrew Huberman has said about peptides

Huberman, a neuroscientist, was Rogan’s guest on episode #1683. On his own podcast, Huberman Lab, he has described trying several compounds:

  • Sermorelin (April 2024): taken “on and off for the last couple of years”, one to two nights a week. He then almost stopped, because it seemed to cut his REM sleep (episode).
  • NAD+ (October 2024): an infusion during his second COVID-19 infection. He felt much better soon after, and said it was correlation, not causation, and could have been the saline bag (episode).
  • Pinealon (October 2024 and June 2026): he said it improved his sleep, including on nights he didn’t take it (episode). In June 2026 he said he uses it about three times a month, not regularly (episode).
  • BPC-157 (June 2026): tried through a compounding pharmacy, but “I don’t take it currently” (episode).

What the research shows for each: sermorelin, NAD+ injection, pinealon and BPC-157.

Nothing on this page is a recommendation to take any of these compounds.

Common questions

What peptides does Joe Rogan take?

The one peptide he has named in a statement I could confirm is BPC-157. On episode 1683 of his podcast, released 14 July 2021, he said elbow tendonitis he could not fix was gone within two weeks of starting it. The Associated Press reported the same account in November 2025. He also said he had an NAD drip while ill with COVID-19 in September 2021, but NAD is not a peptide. Neither statement says what he takes now.

Does Joe Rogan use BPC-157?

He said in July 2021 that he had used it for elbow tendonitis and that the problem was gone within two weeks. The Associated Press quoted the same account in November 2025 and said he has repeatedly praised BPC-157. Neither source says whether he uses it now. BPC-157 is not FDA-approved and is sold as a research chemical labelled not for human use.

Did Joe Rogan take NAD?

Yes, by his own account. In an Instagram video on 1 September 2021 announcing that he had COVID-19, he said he had an NAD drip and a vitamin drip three days in a row. He also listed monoclonal antibodies, ivermectin, a Z-Pak and prednisone. CBS News and Variety reported it. A drip goes into a vein, and the reports name no dose, brand or oral NAD supplement. Because he took several treatments at once, his recovery cannot be credited to any one of them.

What peptide company does Joe Rogan use?

None of the statements confirmed for this page names a supplier, so I cannot say. Research peptides like BPC-157 are sold labelled not for human use, and no regulator checks that a vial matches its label. The vendor checklist on this site shows how to check any seller. Look for a batch-specific certificate of analysis, purity and identity testing, and a testing lab you can identify.

What has Andrew Huberman said about peptides?

On his own podcast, Huberman has said he took sermorelin on and off for a couple of years before almost stopping (April 2024). He also said he felt better after an NAD infusion during a COVID-19 infection, which he called correlation, not causation (October 2024). In June 2026 he said he had tried BPC-157 through a compounding pharmacy but was not taking it. He said he uses pinealon about three times a month, not regularly.

References (16 sources)

Bibliographic detail is fetched from PubMed, not written by me - so a citation here cannot drift from the paper it names. Study design comes from PubMed's own tags rather than my judgement.

  1. 1.Gwyer D, Wragg NM, Wilson SL. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019;377(2):153-159.ReviewPMID 30915550
  2. 2.Lee E, Padgett B. Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain. Altern Ther Health Med. 2021;27(4):8-13.StudyPMID 34324435
  3. 3.Grant R, Berg J, Mestayer R et al. A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD. Front Aging Neurosci. 2019;11:257.StudyPMID 31572171full text
  4. 4.Reyna K, Heinzen G, Patel N et al. Intravenous infusion of nicotinamide adenine dinucleotide (NAD(+)) versus nicotinamide riboside (NR): a retrospective tolerability pilot study in a real-world setting. Front Aging. 2026;7:1652582.StudyPMID 41704678full text
  5. 5.The Joe Rogan Experience #1683 with Andrew Huberman, released 14 July 2021 - automatic episode transcript (no speaker labels). The BPC-157 and elbow tendonitis passage is at 2:40:16 to 2:40:38.- Podscripts (episode transcript)other
  6. 6.Associated Press (Matthew Perrone), 14 November 2025 - Americans are injecting themselves with unproven peptides. Quotes Rogan telling his podcast audience BPC-157 cleared his elbow tendonitis in two weeks.- Associated Press, via ABC11news
  7. 7.CBS News, first published 1 September 2021 (republished by News 9, 2 September) - Joe Rogan says he has COVID-19 and lists his treatments from his Instagram video, including an NAD drip.- CBS News, via News 9 (KWTV, Oklahoma City)news
  8. 8.Variety (William Earl), 8 September 2021 - quotes the treatments Rogan listed in his 1 September Instagram video, including an NAD drip and a vitamin drip.- Varietynews
  9. 9.FDA briefing document for the Pharmacy Compounding Advisory Committee, 23-24 July 2026 - evaluation of BPC-157 bulk drug substances, including the five published human studies.- US Food and Drug Administrationregulatory
  10. 10.ABC News, 23 July 2026 - FDA advisory committee votes 8-6, with one abstention, to add BPC-157 to the drug compounding list; the vote is non-binding.- ABC Newsnews
  11. 11.Federal Register search for "BPC-157", 3 October 2026 - one document, the 16 April 2026 advisory committee meeting notice; no rule adding it to the 503A Bulks List.- Federal Registerdatabase
  12. 12.FDA warning letter to GenoGenix LLC (#718739, 20 January 2026) - NAD+ not eligible for 503B compounding; three patients sent to the emergency room after NAD+ from one lot; excessive endotoxins in an unopened vial.- US Food and Drug Administrationregulatory
  13. 13.Drugs@FDA - searched 3 October 2026 for nicotinamide adenine dinucleotide (NAD+) and nadide; no approved product found.- US Food and Drug Administration (Drugs@FDA)database
  14. 14.Huberman Lab, 1 April 2024 - Benefits and Risks of Peptide Therapeutics for Physical and Mental Health (solo episode, transcript). Huberman on taking sermorelin.- Huberman Lab (episode page and transcript)other
  15. 15.Huberman Lab, 7 October 2024 - Dr. Craig Koniver: Peptide and Hormone Therapies (transcript). Huberman on pinealon and an NAD infusion during COVID-19.- Huberman Lab (episode page and transcript)other
  16. 16.Huberman Lab, 1 June 2026 - Peptides: The Science, Uses and Safety, with Dr. Abud Bakri (transcript). Huberman on trying BPC-157 and pinealon.- Huberman Lab (episode page and transcript)other

Keep reading

Related guides